Correlation Between Tanvex BioPharma and EirGenix

Can any of the company-specific risk be diversified away by investing in both Tanvex BioPharma and EirGenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tanvex BioPharma and EirGenix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tanvex BioPharma and EirGenix, you can compare the effects of market volatilities on Tanvex BioPharma and EirGenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tanvex BioPharma with a short position of EirGenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tanvex BioPharma and EirGenix.

Diversification Opportunities for Tanvex BioPharma and EirGenix

0.36

Correlation Coefficient

Tanvex BioPharma  EirGenix

Weak diversification

The 3 months correlation between Tanvex and EirGenix is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Tanvex BioPharma and EirGenix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EirGenix and Tanvex BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tanvex BioPharma are associated (or correlated) with EirGenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EirGenix has no effect on the direction of Tanvex BioPharma i.e., Tanvex BioPharma and EirGenix go up and down completely randomly.

Pair Corralation between Tanvex BioPharma and EirGenix

Assuming the 90 days trading horizon Tanvex BioPharma is expected to generate 1.36 times more return on investment than EirGenix. However, Tanvex BioPharma is 1.36 times more volatile than EirGenix. It trades about 0.1 of its potential returns per unit of risk. EirGenix is currently generating about -0.04 per unit of risk. If you would invest  4,210  in Tanvex BioPharma on September 23, 2024 and sell it today you would earn a total of  1,870  from holding Tanvex BioPharma or generate 44.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Tanvex BioPharma  vs.  EirGenix

Tanvex BioPharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tanvex BioPharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

EirGenix

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days EirGenix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Tanvex BioPharma and EirGenix

The main advantage of trading using opposite Tanvex BioPharma and EirGenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tanvex BioPharma position performs unexpectedly, EirGenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EirGenix will offset losses from the drop in EirGenix's long position.

The idea behind Tanvex BioPharma and EirGenix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.